Crossmark

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

Crossref DOI link: https://doi.org/10.1016/j.bjid.2015.12.007

Published Print: 2016-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ortiz-Covarrubias, Alejandro

Fang, Edward

Prokocimer, Philippe G.

Flanagan, Shawn D.

Zhu, Xu

Cabré-Márquez, Jose Francisco

Tanaka, Toshiaki

Passarell, Julie

Fiedler-Kelly, Jill

Nannini, Esteban C.
Funding

Funding for this research was provided by:

Merck

Bayer HealthCare
License Information

Text and Data Mining valid from 2016-03-01

Version of Record valid from 2016-02-02
More Information

This article is maintained by: Elsevier

Article Title: Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2015.12.007

Content Type: article

Copyright: Copyright © 2016 Elsevier Editora Ltda.

Document is current

Any future updates will be listed below